FHB
WST icon

First Hawaiian Bank’s West Pharmaceutical WST Stock Holding History

First Hawaiian Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,077
Closed -$1.99M – 770
2024
Q4 		$1.99M Sell
6,077
-8
-0.1% -$2.52K 0.06% 224
2024
Q3 		$1.83M Sell
6,085
-525
-8% -$161K 0.06% 257
2024
Q2 		$2.18M Sell
6,610
-220
-3% -$77.7K 0.07% 198
2024
Q1 		$2.7M Sell
6,830
-67
-1% -$24.8K 0.08% 175
2023
Q4 		$2.43M Sell
6,897
-298
-4% -$105K 0.08% 189
2023
Q3 		$2.7M Buy
7,195
+90
+1% +$34.8K 0.09% 163
2023
Q2 		$2.72M Buy
7,105
+402
+6% +$144K 0.09% 167
2023
Q1 		$2.32M Buy
6,703
+2,031
+43% +$593K 0.08% 193
2022
Q4 		$1.1M Buy
4,672
+6
+0.1% +$1.42K 0.04% 335
2022
Q3 		$1.15M Sell
4,666
-1
-0% -$305 0.04% 297
2022
Q2 		$1.41M Sell
4,667
-150
-3% -$48.8K 0.05% 267
2022
Q1 		$1.98M Hold
4,817
– – 0.06% 223
2021
Q4 		$2.26M Buy
+4,817
New +$2.07M 0.07% 210
2020
Q3 		– Sell
-2,126
Closed -$483K – 848
2020
Q2 		$483K Sell
2,126
-548
-20% -$108K 0.03% 432
2020
Q1 		$407K Buy
2,674
+345
+15% +$53.1K 0.02% 428
2019
Q4 		$350K Sell
2,329
-726
-24% -$106K 0.02% 621
2019
Q3 		$434K Buy
3,055
+816
+36% +$112K 0.02% 503
2019
Q2 		$280K Buy
2,239
+506
+29% +$59.7K 0.02% 666
2019
Q1 		$191K Sell
1,733
-1,019
-37% -$106K 0.01% 754
2018
Q4 		$270K Buy
2,752
+172
+7% +$18.7K 0.02% 616
2018
Q3 		$318K Buy
+2,580
New +$289K 0.02% 608
2013
Q3 		– Sell
-2,650
Closed -$93K – 519
2013
Q2 		$93K Buy
+2,650
New +$87.2K 0.02% 235

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

First Hawaiian Bank's WST Position: Q1 2025 in Review

First Hawaiian Bank sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 6,077 shares — an estimated $1.99M sold.

First Hawaiian Bank first reported a position in WST in Q2 2013 and held it in 22 quarters. The position peaked at $2.72M in Q2 2023. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • First Hawaiian Bank reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 6,077 West Pharmaceutical shares in Q1 2025, an estimated $1.99M.
  • First Hawaiian Bank first reported a position in West Pharmaceutical in Q2 2013 and held it in 22 quarters.
  • First Hawaiian Bank's West Pharmaceutical position peaked at $2.72M in Q2 2023.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.